On ECHEMI
Home > Drugs > Progressive muscular dystrophy
Progressive muscular dystrophy
Progressive myodystrophy is a group of primary skeletal muscle diseases caused by genetic factors. Its main clinical manifestations are slowly progressive muscle atrophy, muscle weakness and varying degrees of movement disorders. This disease can be caused by a variety of genetic factors, and its clinical manifestations have different characteristics, thus forming many types. This section only briefly introduces the more important types.
  • Site of disease:

    muscle
  • Infectious :

    Not contagious
  • Frequent population:

    It is a sex-linked recessive inheritance type, autosomal...
  • Related symptoms:

    Drooping eyelids indifferent expression easy to fall duck-walk gait stiff joints
  • Concurrent disease:

Related Drugs
Bozhi Glycopeptide Injection
Indication: It is used for progressive muscular dystrophy, myotonia atrophica, vertigo caused by vestibular dysfunction, hypertension, autonomic dysfunction, epilepsy, insomnia, etc. It can also be used as an auxiliary treatment for tumors and hepatitis.
Manufacturer:

Beijing Science Sun Pharmaceutical Co., Ltd.

Related Ingredients
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.